> top > docs > PubMed:23742877 > annotations

PubMed:23742877 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 315-330 HP_0012125 denotes prostate cancer
T2 324-330 HP_0002664 denotes cancer
T3 629-644 HP_0012125 denotes prostate cancer
T4 638-644 HP_0002664 denotes cancer

chenxin_473849_800

Id Subject Object Predicate Lexical cue
T1 109-145 DP denotes castration-resistant prostate cancer
T2 147-153 DP denotes VENICE
T3 210-219 CI denotes Docetaxel
T4 47-56 CI denotes docetaxel
T5 531-540 CI denotes docetaxel
T6 686-695 CI denotes docetaxel
T7 979-988 CI denotes docetaxel
T8 2617-2626 CI denotes docetaxel
T9 700-710 CI denotes prednisone
T10 61-71 CI denotes prednisone
T11 225-235 CI denotes prednisone
T12 545-555 CI denotes prednisone
T13 1039-1049 CI denotes prednisone
T14 2631-2641 CI denotes prednisone
T15 2838-2848 CI denotes prednisone
T16 1109-1120 CI denotes aflibercept
T17 516-527 CI denotes aflibercept
T18 2070-2081 CI denotes aflibercept
T19 2524-2535 CI denotes aflibercept
T20 0-11 CI denotes Aflibercept
T21 332-343 CI denotes Aflibercept
T22 1541-1552 CI denotes Aflibercept
T23 2585-2596 CI denotes Aflibercept

Linmchun_800_3

Id Subject Object Predicate Lexical cue
T1 979-988 CI denotes docetaxel
T10 675-682 CI denotes placebo
T11 1556-1563 CI denotes placebo
T12 1541-1552 CI denotes Aflibercept
T13 2123-2130 CI denotes placebo
T14 2554-2561 CI denotes placebo
T15 2814-2821 CI denotes placebo
T16 332-343 CI denotes Aflibercept
T17 516-527 CI denotes aflibercept
T18 531-540 CI denotes docetaxel
T19 545-555 CI denotes prednisone
T2 1039-1049 CI denotes prednisone
T20 2070-2081 CI denotes aflibercept
T21 2524-2535 CI denotes aflibercept
T22 2585-2596 CI denotes Aflibercept
T23 2617-2626 CI denotes docetaxel
T24 2631-2641 CI denotes prednisone
T25 2823-2832 CI denotes Docetaxel
T26 2838-2848 CI denotes prednisone
T27 210-219 CI denotes Docetaxel
T28 225-235 CI denotes prednisone
T29 686-695 CI denotes docetaxel
T3 1109-1120 CI denotes aflibercept
T30 700-710 CI denotes prednisone
T31 315-330 DP denotes prostate cancer
T32 629-644 DP denotes prostate cancer
T33 893-908 DP denotes prostate cancer
T34 2718-2733 DP denotes prostate cancer
T35 147-153 DP denotes VENICE
T36 721-727 DP denotes VENICE
T4 1134-1141 CI denotes placebo
T5 0-11 CI denotes Aflibercept
T6 19-26 CI denotes placebo
T7 47-56 CI denotes docetaxel
T8 61-71 CI denotes prednisone
T9 130-145 DP denotes prostate cancer
T37 780-787 CI denotes placebo

luoyt2021_800_3

Id Subject Object Predicate Lexical cue
T1 0-11 CI denotes Aflibercept
T10 147-153 DP denotes VENICE
T11 721-727 DP denotes VENICE
T12 315-330 DP denotes prostate cancer
T14 893-908 DP denotes prostate cancer
T15 2718-2733 DP denotes prostate cancer
T16 2823-2832 CI denotes Docetaxel
T17 2617-2626 CI denotes docetaxel
T18 979-988 CI denotes docetaxel
T19 686-695 CI denotes docetaxel
T2 2585-2596 CI denotes Aflibercept
T20 531-540 CI denotes docetaxel
T21 210-219 CI denotes Docetaxel
T22 47-56 CI denotes docetaxel
T23 2814-2821 CI denotes placebo
T24 2554-2561 CI denotes placebo
T25 2123-2130 CI denotes placebo
T26 1556-1563 CI denotes placebo
T27 1134-1141 CI denotes placebo
T28 780-787 CI denotes placebo
T29 675-682 CI denotes placebo
T3 2524-2535 CI denotes aflibercept
T30 19-26 CI denotes placebo
T31 2838-2848 CI denotes prednisone
T32 2631-2641 CI denotes prednisone
T33 1039-1049 CI denotes prednisone
T34 700-710 CI denotes prednisone
T35 545-555 CI denotes prednisone
T36 225-235 CI denotes prednisone
T37 61-71 CI denotes prednisone
T4 2070-2081 CI denotes aflibercept
T5 1541-1552 CI denotes Aflibercept
T6 1109-1120 CI denotes aflibercept
T7 516-527 CI denotes aflibercept
T8 332-343 CI denotes Aflibercept
T9 130-145 DP denotes prostate cancer
T38 629-644 DP denotes prostate cancer